Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Parkinson Disease l: Introduction

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

Alterations in Muscle Tone lll

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Effects of Exercise on Cancer-Related Cognitive Impairment: An Umbrella Review of Systematic Reviews and Meta-Analysis.

Psycho-oncology·2026

Same author

Neurovictimology and the risks of neurotechnologies and artificial intelligence: a forensic and legal perspective.

Frontiers in psychology·2026

Same author

Decreased interleukin-8 levels in the peripheral blood of Alzheimer's disease patients.

Journal of Alzheimer's disease : JAD·2026

Same author

A Multi-Symptom Circuit Architecture of Obsessive-Compulsive Disorder.

medRxiv : the preprint server for health sciences·2025

Same author

Striatal injection of aminochrome in Wistar rats induces early-stage behavioral changes of Parkinson's disease and dopaminergic degeneration in the caudal and medial regions of the nigra pars compacta.

Neurochemistry international·2025

Same author

Correction: Age- and sex-related development of osteosarcopenia in the aging <i>Octodon degus</i> rodent model.

Frontiers in aging·2025

Search research articles

Related Experiment Videos

Inflammatory response in Parkinsonism.

Carlos Barcia¹, Francisco Ros, María Angeles Carrillo

¹Clinical and Experimental Neuroscience, Department of Human Anatomy, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, School of Medicine, University of Murcia, Campus de Espinardo, Murcia 30100, Spain. barcia@um.es

Journal of Neural Transmission. Supplementum

|April 24, 2010

Summary

This summary is machine-generated.

Inflammation plays a key role in Parkinson's disease neurodegeneration. Glial cell activation and systemic inflammatory changes can worsen Parkinson's, suggesting new therapeutic targets.

Related Experiment Videos

Area of Science:

Neuroscience
Immunology
Pathology

Background:

Neuroinflammation is increasingly implicated in Parkinson's disease pathogenesis.
Neuronal degeneration can trigger detrimental changes in the brain's glial microenvironment.

Observation:

Activated microglia/macrophages and reactive astrocytes contribute to neurodegeneration.
Brain inflammation may extend systemically, releasing cytokines, acute phase proteins (APP), and glucocorticoids (GC).

Findings:

This review synthesizes current research on inflammatory responses in Parkinsonism.
Evidence links glial activation and systemic inflammation to disease progression.

Implications:

Understanding these inflammatory pathways may reveal novel therapeutic strategies for Parkinson's disease.
Targeting neuroinflammation could offer new treatment avenues for patients.